Xencor | XNCR - Laba Operasional





Laba Operasional Perubahan Tanggal
AbbVie USD 4.73B 1.08B 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amgen USD 3.83B 130M 2026-03
Arrowhead Research USD 40.81M 3.3M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
Biogen USD 514.3M 128.8M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
J&J USD 6.62B 1.03B 2026-03
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
MacroGenics USD -12.1M 30.74M 2025-12
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.65B 3.99B 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Xencor USD -53.63M 6.11M 2025-12